Sarah Thacker

Sarah Thacker is a highly experienced scientific professional currently serving as an In Vitro Pharmacology Senior Scientist II at SpringWorks Therapeutics since October 2023. Previously, Sarah held the positions of Principal Scientist and Senior Scientist at Lonza from August 2019 to October 2023, focusing on developing and validating novel primary human cell biology products. Sarah's background includes leadership roles in R&D at Vitrisa Therapeutics and extensive postdoctoral research at the University of North Carolina at Chapel Hill and The Hamner Institutes, where significant contributions were made to understanding drug-induced liver injury biomarkers. Educational qualifications include a Doctorate in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill and a Bachelor's in Chemistry from Washington College.